Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Health Serv Res
Autors principals: Mansell, Kerry, Bhimji, Hishaam, Eurich, Dean, Mansell, Holly
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Correction
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918652/
https://ncbi.nlm.nih.gov/pubmed/31849317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-019-4829-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars